InsideTrading SEC Form 4 insider trades

Stocks

BJDX Bluejay Diagnostics, Inc.

Healthcare · Market cap: $11.7M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $142.8K, sold $0 2022-Q2: bought $19.8K, sold $0 2022-Q3: bought $20.6K, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $8.8K, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $3.2K, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $0, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $0, sold $0 2026-Q1: bought $125.0K, sold $0 2026-Q2: bought $0, sold $0 2026-Q3: bought $96.7K, sold $48.9K 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $142.8K) Sold, below the line (largest quarter $48.9K)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$142.8K$0
2022-Q2$19.8K$0
2022-Q3$20.6K$0
2022-Q4$0$0
2023-Q1$8.8K$0
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$3.2K$0
2024-Q1$0$0
2024-Q2$0$0
2024-Q3$0$0
2024-Q4$0$0
2025-Q1$0$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$0$0
2026-Q1$125.0K$0
2026-Q2$0$0
2026-Q3$96.7K$48.9K
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$416.9K20 buy days
Sold$48.9K1 sell day
Net insider flow+$368.0Knet buying · 5 years
Latest trade2026-07-10HRT FINANCIAL LP
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-07-10 Sell HRT FINANCIAL LP 10% owner 34,938 $1.40 $48.9K 1
2026-07-09 Buy HRT FINANCIAL LP 10% owner 64,047 $1.51 $96.7K 1
2026-03-14 Buy Dey Svetlana Director 12,500 $2.00 $25.0K 1
2026-03-14 Buy CHASE DONALD R Director 12,500 $2.00 $25.0K 1
2026-03-14 Buy Wurth Douglas Clark Director 12,500 $2.00 $25.0K 1
2026-03-14 Buy Dey Indranil CEO 12,500 $2.00 $25.0K 1
2026-03-14 Buy ZEIDMAN FRED S Director 12,500 $2.00 $25.0K 1
2023-12-13 Buy Dey Indranil CEO 500 $3.27 $1.6K 1
2023-12-13 Buy Dey Svetlana Director 500 $3.07 $1.5K 1
2023-03-28 Buy Dey Indranil CEO 2,000 $0.44 $880 1
2023-03-27 Buy Dey Indranil CEO 8,000 $0.44 $3.5K 1
2023-03-24 Buy Dey Svetlana Director 10,000 $0.44 $4.4K 1
2022-08-26 Buy Fisher Kenneth R CFO 20,000 $1.03 $20.6K 1
2022-04-25 Buy Fisher Kenneth R CFO 20,000 $0.99 $19.8K 1
2022-03-17 Buy Wurth Douglas Clark Director 40,000 $1.18 $47.2K 1
2022-03-17 Buy Dey Svetlana Director 10,000 $1.18 $11.8K 1
2022-03-17 Buy Kinder Gordon Winston CFO 2,500 $1.16 $2.9K 1
2022-03-16 Buy Wurth Douglas Clark Director 60,000 $1.09 $65.4K 1
2022-03-16 Buy Kinder Gordon Winston CFO 5,000 $1.02 $5.1K 1
2022-03-15 Buy Kinder Gordon Winston CFO 500 $0.91 $455 1
2022-03-14 Buy Kinder Gordon Winston CFO 10,500 $0.95 $10.0K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
HRT FINANCIAL LP 10% owner $96.7K $48.9K 2026-07-10
Wurth Douglas Clark Director $137.6K $0 2026-03-14
Dey Svetlana Director $42.7K $0 2026-03-14
Fisher Kenneth R CFO $40.4K $0 2022-08-26
Dey Indranil CEO $31.0K $0 2026-03-14
CHASE DONALD R Director $25.0K $0 2026-03-14
ZEIDMAN FRED S Director $25.0K $0 2026-03-14
Kinder Gordon Winston CFO $18.4K $0 2022-03-17

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2026-03-14 5 $125.0K 38 +154.1% (+162.4% raw)-54.0% (-43.5% raw)– closed
2022-03-14 → 2022-03-17 3 $142.8K 40 -18.6% (-22.5% raw)+5.7% (-12.6% raw)-18.5% (-33.1% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.